Back to Newsroom

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015

GAITHERSBURG, Md., Aug. 03, 2015 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its second quarter 2015 financial and operating results after the close of U.S. financial markets on Monday, August 10, 2015.

Click here to read more